Expand ELDN Menu
ELDN MENU

ELDN Latest Press Releases

-- July 8, 2026 --

The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy PRNewswire 9:01 AM

-- July 1, 2026 --

NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes Globe Newswire 9:30 AM

-- June 25, 2026 --

Natera and Eledon Announce Strategic Partnership for Prospera Monitoring in Planned Phase 3 Kidney Transplant Trial Business Wire 7:00 AM

-- June 22, 2026 --

Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus Globe Newswire 7:00 AM

-- June 8, 2026 --

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine Globe Newswire 7:00 AM

-- June 4, 2026 --

Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions Globe Newswire 4:31 PM

-- May 27, 2026 --

NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes Globe Newswire 7:55 AM

-- May 20, 2026 --

Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress Globe Newswire 4:05 PM

-- May 13, 2026 --

Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights Globe Newswire 4:05 PM

-- April 30, 2026 --

NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026 Globe Newswire 8:15 AM

-- April 20, 2026 --

NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference Globe Newswire 7:37 AM

-- March 19, 2026 --

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results Globe Newswire 5:10 PM

-- March 16, 2026 --

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine Globe Newswire 7:00 AM

-- March 10, 2026 --

Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation Globe Newswire 7:00 AM

-- March 9, 2026 --

NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes PRNewswire 7:00 AM

-- March 4, 2026 --

Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes